中外製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/11/26 | 4,700 | 4,820 | 4,676 | 4,803 | +134 | +2.9% | 2,055,900 |
2020/11/25 | 4,588 | 4,694 | 4,572 | 4,669 | +107 | +2.3% | 2,550,700 |
2020/11/24 | 4,506 | 4,583 | 4,485 | 4,562 | +131 | +3% | 2,311,100 |
2020/11/20 | 4,548 | 4,564 | 4,424 | 4,431 | -144 | -3.1% | 1,974,500 |
2020/11/19 | 4,500 | 4,578 | 4,500 | 4,575 | +50 | +1.1% | 2,530,800 |
2020/11/18 | 4,546 | 4,609 | 4,484 | 4,525 | +5 | +0.1% | 1,526,000 |
2020/11/17 | 4,582 | 4,600 | 4,472 | 4,520 | -107 | -2.3% | 2,243,000 |
2020/11/16 | 4,615 | 4,660 | 4,585 | 4,627 | +43 | +0.9% | 1,841,700 |
2020/11/13 | 4,627 | 4,627 | 4,539 | 4,584 | -38 | -0.8% | 2,414,500 |
2020/11/12 | 4,662 | 4,680 | 4,590 | 4,622 | -49 | -1% | 2,745,500 |
2020/11/11 | 4,607 | 4,704 | 4,580 | 4,671 | +134 | +3% | 2,971,200 |
2020/11/10 | 4,595 | 4,600 | 4,504 | 4,537 | +64 | +1.4% | 2,424,400 |
2020/11/09 | 4,452 | 4,505 | 4,412 | 4,473 | +44 | +1% | 2,254,400 |
2020/11/06 | 4,599 | 4,607 | 4,416 | 4,429 | -183 | -4% | 2,651,000 |
2020/11/05 | 4,499 | 4,613 | 4,464 | 4,612 | +298 | +6.9% | 4,201,100 |
2020/11/04 | 4,177 | 4,323 | 4,094 | 4,314 | +241 | +5.9% | 2,490,400 |
2020/11/02 | 4,047 | 4,093 | 4,022 | 4,073 | +52 | +1.3% | 1,508,200 |
2020/10/30 | 4,100 | 4,100 | 4,020 | 4,021 | -104 | -2.5% | 1,986,500 |
2020/10/29 | 4,150 | 4,198 | 4,116 | 4,125 | -27 | -0.7% | 1,798,200 |
2020/10/28 | 4,171 | 4,211 | 4,147 | 4,152 | -27 | -0.6% | 1,382,300 |
2020/10/27 | 4,165 | 4,189 | 4,146 | 4,179 | +12 | +0.3% | 1,364,600 |
2020/10/26 | 4,211 | 4,240 | 4,147 | 4,167 | -114 | -2.7% | 1,743,500 |
2020/10/23 | 4,188 | 4,305 | 4,151 | 4,281 | +125 | +3% | 2,761,200 |
2020/10/22 | 4,193 | 4,205 | 4,142 | 4,156 | -149 | -3.5% | 1,581,700 |
2020/10/21 | 4,330 | 4,337 | 4,272 | 4,305 | -48 | -1.1% | 1,591,700 |
2020/10/20 | 4,367 | 4,420 | 4,326 | 4,353 | -40 | -0.9% | 1,301,900 |
2020/10/19 | 4,374 | 4,408 | 4,352 | 4,393 | +74 | +1.7% | 1,321,900 |
2020/10/16 | 4,367 | 4,376 | 4,295 | 4,319 | -114 | -2.6% | 1,895,500 |
2020/10/15 | 4,467 | 4,489 | 4,416 | 4,433 | -57 | -1.3% | 1,491,900 |
2020/10/14 | 4,467 | 4,513 | 4,458 | 4,490 | ±0 | ±0% | 1,192,600 |
2020/10/13 | 4,536 | 4,541 | 4,473 | 4,490 | -65 | -1.4% | 1,488,000 |
2020/10/12 | 4,565 | 4,598 | 4,543 | 4,555 | -39 | -0.8% | 1,088,100 |
2020/10/09 | 4,671 | 4,682 | 4,551 | 4,594 | -78 | -1.7% | 2,051,900 |
2020/10/08 | 4,658 | 4,703 | 4,608 | 4,672 | +59 | +1.3% | 1,799,900 |
2020/10/07 | 4,612 | 4,630 | 4,571 | 4,613 | -37 | -0.8% | 2,007,000 |
2020/10/06 | 4,612 | 4,660 | 4,586 | 4,650 | +31 | +0.7% | 1,069,400 |
2020/10/05 | 4,609 | 4,683 | 4,586 | 4,619 | +42 | +0.9% | 1,347,900 |
2020/10/02 | 4,722 | 4,760 | 4,567 | 4,577 | - | - | 2,659,400 |
2020/10/01 | 0 | 0 | 0 | 0 | - | - | 0 |
2020/09/30 | 4,733 | 4,774 | 4,715 | 4,715 | -25 | -0.5% | 2,614,600 |
2020/09/29 | 4,746 | 4,750 | 4,657 | 4,740 | -20 | -0.4% | 1,985,300 |
2020/09/28 | 4,730 | 4,762 | 4,688 | 4,760 | +59 | +1.3% | 1,969,600 |
2020/09/25 | 4,699 | 4,731 | 4,685 | 4,701 | +15 | +0.3% | 1,806,700 |
2020/09/24 | 4,750 | 4,793 | 4,681 | 4,686 | -119 | -2.5% | 1,809,500 |
2020/09/23 | 4,743 | 4,806 | 4,701 | 4,805 | +94 | +2% | 2,492,500 |
2020/09/18 | 4,749 | 4,756 | 4,673 | 4,711 | -108 | -2.2% | 3,248,800 |
2020/09/17 | 4,778 | 4,828 | 4,770 | 4,819 | +41 | +0.9% | 1,318,200 |
2020/09/16 | 4,717 | 4,778 | 4,688 | 4,778 | +10 | +0.2% | 1,469,400 |
2020/09/15 | 4,755 | 4,781 | 4,711 | 4,768 | +56 | +1.2% | 1,373,900 |
2020/09/14 | 4,750 | 4,758 | 4,691 | 4,712 | -70 | -1.5% | 1,247,200 |
1151~
1200
件表示中 / 3758件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
中外薬 | 740,000円 | +1.7% | +5.0% | 3.38% | 29.70倍 | 6.13倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
第一三共 | 360,000円 | +6.0% | +4.0% | 2.17% | 22.21倍 | 4.10倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
武 田 | 423,000円 | -1.1% | +75.3% | 4.73% | 29.30倍 | 0.96倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 763,900円 | +2.2% | +28.0% | 1.83% | 12.23倍 | 1.48倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 160,400円 | +0.9% | +380.2% | 4.86% | 22.10倍 | 1.90倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム